Correction to: Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy (Drug Safety, (2021), 44, 10, (1109-1119), 10.1007/s40264-021-01107-6)
- John W. Day
- , Jerry R. Mendell
- , Eugenio Mercuri
- , Richard S. Finkel
- , Kevin A. Strauss
- , Aaron Kleyn
- , Sitra Tauscher-Wisniewski
- , Francis Fonyuy Tukov
- , Sandra P. Reyna
- , Deepa H. Chand
Research output: Contribution to journal › Comment/debate
3
Link opens in a new tab
Scopus
citations